CRISPR Therapeutics AG

CRSP NASDAQ Santé & Biotech Monde CH0334081137
52.08 $
0.12 %

CRISPR Therapeutics est centrée sur le développement de thérapies géniques utilisant la technologie CRISPR-Cas9 pour le traitement de maladies génétiques graves.

Performance & Momentum

6 Months 7.69 %
1 Year 54.81 %
3 Years 13.07 %
5 Years 50.41 %

Similar stocks to CRISPR Therapeutics AG

Anantys Community

Be the first to share your analysis on CRISPR Therapeutics AG.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases